Recordati Industria Chimica e Farmaceutica SPA (RECN) Q2 2021 Earnings Report
MX:RECN Q2 2021 EPS Results
- Actual EPS
- MXN 10.10
- Consensus EPS
- MXN 8.60
- Beat/Miss
- Beat by +MXN 1.50
- One Year Ago EPS
- MXN 8.63
MX:RECN Q2 2021 Revenue Results
- Actual Revenue
- MXN 8.13B
- Expected Revenue
- MXN 7.06B
- Beat/Miss
- Beat by +MXN 1.06B
- YoY Revenue Growth
- +16.63%
Earnings Announcement Details
- Quarter
- Q2 2021
- Date
- 07/29/2021
- Time
- TBA
- Conference Call
- Thursday, July 29, 2021
MX:RECN Upcoming Earnings
Recordati Industria Chimica e Farmaceutica SPA's next earnings date is estimated for November 10, 2026, based on past reporting schedules.
Q2 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:RECN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 10, 2026 | 2026 (Q3) | ―- | 16.63 | ― | ― |
| Jul 28, 2026 | 2026 (Q2) | ―27.20 | 21.75 | 25.07% (+5.45) | |
| May 12, 2026 | 2026 (Q1) | ―15.41 | 12.59 | 22.41% (+2.82) | |
| Feb 17, 2026 | 2025 (Q4) | 15.3712.08 | 7.98 | 51.45% (+4.11) | |
| Nov 11, 2025 | 2025 (Q3) | ―16.63 | 14.53 | 14.49% (+2.11) | |
| Jul 29, 2025 | 2025 (Q2) | 16.1021.75 | 14.1 | 54.18% (+7.64) | |
| May 08, 2025 | 2025 (Q1) | ―12.59 | 12.44 | 1.18% (+0.15) | |
| Feb 13, 2025 | 2024 (Q4) | ―7.98 | 8.65 | -7.79% (-0.67) | |
| Nov 08, 2024 | 2024 (Q3) | 14.3114.53 | 12 | 21.05% (+2.53) | |
| Jul 30, 2024 | 2024 (Q2) | 13.6814.10 | 13.26 | 6.35% (+0.84) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed